Vera Therapeutics (VERA) News Today $22.29 +0.27 (+1.23%) Closing price 04:00 PM EasternExtended Trading$21.86 -0.43 (-1.95%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Vera Therapeutics, Inc. $VERA Shares Bought by Price T Rowe Associates Inc. MDAugust 28 at 5:06 AM | marketbeat.comEvercore ISI Sticks to Their Buy Rating for Vera Therapeutics (VERA)August 27 at 2:34 AM | theglobeandmail.comVera Therapeutics to Participate at Upcoming Investor ConferencesAugust 26 at 4:05 PM | globenewswire.comVera Therapeutics, Inc. $VERA Shares Bought by T. Rowe Price Investment Management Inc.August 26 at 4:49 AM | marketbeat.comRussell Investments Group Ltd. Purchases 127,646 Shares of Vera Therapeutics, Inc. $VERAAugust 26 at 3:42 AM | marketbeat.comVanguard Group Inc. Cuts Stock Position in Vera Therapeutics, Inc. $VERAAugust 26 at 3:05 AM | marketbeat.comVera Therapeutics, Inc. $VERA Stake Boosted by Algert Global LLCAugust 24, 2025 | marketbeat.com19,597 Shares in Vera Therapeutics, Inc. $VERA Acquired by Fox Run Management L.L.C.August 21, 2025 | marketbeat.comLord Abbett & CO. LLC Has $3.57 Million Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)August 19, 2025 | marketbeat.comCan Vera Therapeutics’ (VERA) Widening Losses Challenge Its Path to Sustainable Growth?August 19, 2025 | finance.yahoo.comDeutsche Bank AG Purchases 82,483 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)August 15, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 10, 2025 | marketbeat.comFY2025 EPS Estimates for VERA Cut by Cantor FitzgeraldAugust 9, 2025 | marketbeat.comHC Wainwright Has Negative Estimate for VERA Q3 EarningsAugust 9, 2025 | marketbeat.comWhat is Lifesci Capital's Forecast for VERA Q3 Earnings?August 9, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Vera Therapeutics (NASDAQ:VERA) Stock PriceAugust 8, 2025 | marketbeat.comVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 | globenewswire.comVera Therapeutics Signs New Sales Agreement with TD SecuritiesAugust 8, 2025 | theglobeandmail.comQ3 Earnings Forecast for Vera Therapeutics Issued By WedbushAugust 8, 2025 | marketbeat.comVera Therapeutics (VERA) to Release Quarterly Earnings on ThursdayAugust 7, 2025 | marketbeat.comVera Therapeutics (NASDAQ:VERA) Posts Earnings Results, Misses Estimates By $0.38 EPSAugust 6, 2025 | marketbeat.comVera (VERA) Q2 Net Loss Widens 127%August 6, 2025 | fool.comVera Therapeutics (NASDAQ:VERA) Shares Gap Down - What's Next?August 5, 2025 | marketbeat.comWolfe Research Downgrades Vera Therapeutics (VERA)August 5, 2025 | msn.comVera Therapeutics' (VERA) "Peer Perform" Rating Reaffirmed at Wolfe ResearchAugust 5, 2025 | marketbeat.comVera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | globenewswire.comTD Asset Management Inc Raises Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)August 3, 2025 | marketbeat.comShort Interest in Vera Therapeutics, Inc. (NASDAQ:VERA) Rises By 5,059.7%August 2, 2025 | marketbeat.comFederated Hermes Inc. Cuts Stake in Vera Therapeutics, Inc. (NASDAQ:VERA)August 2, 2025 | marketbeat.comPolycythemia Vera Market Expands as FDA Fast Tracks New Treatments and Clinical Trials Show Promising Results | DelveInsightAugust 1, 2025 | theglobeandmail.comRAPT Therapeutics (RAPT) was upgraded to a Hold Rating at J.P. MorganAugust 1, 2025 | theglobeandmail.comDecheng Capital LLC Cuts Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)July 31, 2025 | marketbeat.comY Intercept Hong Kong Ltd Makes New $293,000 Investment in Vera Therapeutics, Inc. (NASDAQ:VERA)July 31, 2025 | marketbeat.comBehind The Volatility Of Vera TherapeuticsJuly 27, 2025 | seekingalpha.comVictory Capital Management Inc. Lowers Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)July 27, 2025 | marketbeat.comGW&K Investment Management LLC Grows Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)July 23, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Stake Decreased by Jennison Associates LLCJuly 21, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 15, 2025 | marketbeat.comVera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 10, 2025 | globenewswire.comVera Therapeutics Reports Positive Phase 3 ORIGIN Trial Results for Atacicept in IgA NephropathyJuly 6, 2025 | msn.comVera Therapeutics Inc Class A Sustainability - MorningstarJuly 5, 2025 | morningstar.comMVera Therapeutics director Enright buys shares worth $5.2mJune 27, 2025 | investing.comVor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in FundingJune 27, 2025 | msn.comVera Therapeutics (NASDAQ:VERA) Shares Gap Up Following Insider Buying ActivityJune 26, 2025 | marketbeat.comInsider Buying: Vera Therapeutics, Inc. (NASDAQ:VERA) Director Acquires 40,607 Shares of StockJune 26, 2025 | insidertrades.comVera Therapeutics, Inc. (NASDAQ:VERA) Director Patrick G. Enright Purchases 40,607 SharesJune 25, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Director Patrick G. Enright Acquires 209,393 SharesJune 25, 2025 | marketbeat.comPolycythemia Vera Market Set for Strong Growth Across Key Markets, Backed by Emerging Treatments and Epidemiological Trends | DelveInsightJune 24, 2025 | theglobeandmail.comBAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsightJune 24, 2025 | finance.yahoo.comVera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of "Buy" by BrokeragesJune 20, 2025 | marketbeat.com Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VERA Media Mentions By Week VERA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERA News Sentiment▼1.331.03▲Average Medical News Sentiment VERA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERA Articles This Week▼86▲VERA Articles Average Week Get the Latest News and Ratings for VERA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Nuvalent News Today Merus News Today CRISPR Therapeutics News Today TG Therapeutics News Today Cytokinetics News Today Ascentage Pharma Group International News Today Krystal Biotech News Today ACADIA Pharmaceuticals News Today ADMA Biologics News Today Telix Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access